Bionime Corporation(TW:4737)
NT$55.70+0.20 (+0.36%)
TW:4737
Bionime Corporation financials statements
NT$55.70
At close:+0.20 (+0.36%)
Bionime Corporation (4737) Ratios
Bionime Corporation Ratios
TW:4737's free cash flow for Q2 2026 was NT$-98.56M. For the 2026 fiscal year, TW:4737's free cash flow was decreased by NT$-5.55M and operating cash flow was NT$-93.01M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.75 | 0.77 | 1.01 | 1.16 | 1.05 |
| Quick Ratio | 0.53 | 0.52 | 0.70 | 0.78 | 0.60 |
| Cash Ratio | 0.20 | 0.14 | 0.24 | 0.15 | 0.19 |
| Solvency Ratio | 0.00 | 0.01 | 0.05 | 0.08 | 0.10 |
| Operating Cash Flow Ratio | 0.24 | 0.01 | 0.13 | 0.10 | 0.20 |
| Short-Term Operating Cash Flow Coverage | 0.42 | 0.01 | 0.18 | 0.18 | 0.31 |
| Net Current Asset Value | NT$ -2.39B | NT$ -2.12B | NT$ -1.69B | NT$ -1.27B | NT$ -1.10B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.54 | 0.55 | 0.53 | 0.46 | 0.45 |
| Debt-to-Equity Ratio | 1.75 | 1.68 | 1.42 | 1.10 | 0.98 |
| Debt-to-Capital Ratio | 0.64 | 0.63 | 0.59 | 0.52 | 0.50 |
| Long-Term Debt-to-Capital Ratio | 0.52 | 0.46 | 0.46 | 0.42 | 0.36 |
| Financial Leverage Ratio | 3.27 | 3.08 | 2.67 | 2.40 | 2.21 |
| Debt Service Coverage Ratio | 0.04 | 0.07 | 0.19 | 0.34 | 0.30 |
| Interest Coverage Ratio | -3.04 | -2.08 | -0.28 | 4.79 | 3.84 |
| Debt to Market Cap | 0.76 | 0.80 | 0.61 | 0.48 | 0.44 |
| Interest Debt Per Share | 46.00 | 48.19 | 42.57 | 34.59 | 31.06 |
| Net Debt to EBITDA | -174.86 | 47.99 | 13.49 | 7.60 | 7.16 |
| Profitability Margins | |||||
| Gross Profit Margin | 34.15% | 39.74% | 40.76% | 45.42% | 42.33% |
| EBIT Margin | -10.73% | -6.39% | 0.93% | 5.30% | 5.06% |
| EBITDA Margin | -0.82% | 3.07% | 10.24% | 12.23% | 13.42% |
| Operating Profit Margin | -10.73% | -6.67% | -0.76% | 6.64% | 3.95% |
| Pretax Profit Margin | -13.57% | -9.60% | -1.82% | 3.91% | 4.03% |
| Net Profit Margin | -9.81% | -6.58% | 0.35% | 4.12% | 4.73% |
| Continuous Operations Profit Margin | -9.75% | -6.52% | 0.37% | 4.15% | 4.83% |
| Net Income Per EBT | 72.28% | 68.50% | -19.48% | 105.25% | 117.20% |
| EBT Per EBIT | 126.37% | 143.91% | 238.96% | 58.95% | 102.07% |
| Return on Assets (ROA) | -3.16% | -2.20% | 0.12% | 1.83% | 1.92% |
| Return on Equity (ROE) | -10.33% | -6.77% | 0.31% | 4.39% | 4.22% |
| Return on Capital Employed (ROCE) | -5.44% | -3.72% | -0.36% | 4.11% | 2.26% |
| Return on Invested Capital (ROIC) | -2.94% | -1.73% | 0.06% | 3.37% | 1.78% |
| Return on Tangible Assets | -3.77% | -2.54% | 0.13% | 2.03% | 2.07% |
| Earnings Yield | -4.50% | -3.23% | 0.14% | 1.95% | 1.92% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.40 | 2.68 | 3.37 | 3.13 | 4.78 |
| Payables Turnover | 8.55 | 6.09 | 7.04 | 6.73 | 7.06 |
| Inventory Turnover | 2.65 | 2.04 | 2.12 | 2.24 | 1.81 |
| Fixed Asset Turnover | 0.66 | 0.67 | 0.62 | 0.82 | 0.69 |
| Asset Turnover | 0.32 | 0.33 | 0.33 | 0.44 | 0.41 |
| Working Capital Turnover Ratio | -3.49 | -7.32 | 15.01 | 15.46 | 13.38 |
| Cash Conversion Cycle | 202.20 | 255.37 | 228.78 | 225.45 | 226.59 |
| Days of Sales Outstanding | 107.31 | 136.43 | 108.19 | 116.76 | 76.38 |
| Days of Inventory Outstanding | 137.59 | 178.89 | 172.43 | 162.90 | 201.92 |
| Days of Payables Outstanding | 42.70 | 59.95 | 51.84 | 54.21 | 51.71 |
| Operating Cycle | 244.90 | 315.32 | 280.62 | 279.66 | 278.30 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 7.28 | 0.29 | 3.02 | 2.14 | 4.09 |
| Free Cash Flow Per Share | 3.04 | -4.68 | -3.53 | -2.56 | -0.22 |
| Dividend Paid and CapEx Coverage Ratio | 1.72 | 0.04 | 0.36 | 0.33 | 0.66 |
| Capital Expenditure Coverage Ratio | 1.72 | 0.06 | 0.46 | 0.45 | 0.95 |
| Operating Cash Flow Coverage Ratio | 0.16 | 0.01 | 0.07 | 0.06 | 0.13 |
| Operating Cash Flow to Sales Ratio | 0.27 | 0.01 | 0.12 | 0.06 | 0.15 |
| Free Cash Flow Yield | 5.16% | -7.94% | -5.19% | -3.65% | -0.33% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -22.24 | -30.84 | 748.66 | 51.52 | 51.96 |
| Price-to-Sales (P/S) Ratio | 2.18 | 2.04 | 2.61 | 2.11 | 2.46 |
| Price-to-Book (P/B) Ratio | 2.29 | 2.10 | 2.31 | 2.26 | 2.20 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 19.39 | -12.59 | -19.25 | -27.39 | -306.71 |
| Price-to-Operating Cash Flow Ratio | 8.09 | 201.97 | 22.52 | 32.84 | 16.88 |
| Price-to-Earnings Growth (PEG) Ratio | -0.57 | 0.01 | -8.02 | 18.80 | 1.38 |
| Enterprise Value Multiple | -440.34 | 114.52 | 38.97 | 24.89 | 25.50 |
| Enterprise Value | 6.64B | 6.79B | 7.01B | 6.73B | 6.33B |
| EV to EBITDA | -440.34 | 114.52 | 38.97 | 24.89 | 25.50 |
| EV to Sales | 3.61 | 3.51 | 3.99 | 3.04 | 3.42 |
| EV to Free Cash Flow | 32.17 | -21.67 | -29.45 | -39.44 | -426.50 |
| EV to Operating Cash Flow | 13.42 | 347.65 | 34.44 | 47.29 | 23.48 |
| Tangible Book Value Per Share | 12.31 | 16.61 | 20.05 | 23.66 | 26.26 |
| Shareholders’ Equity Per Share | 25.70 | 28.06 | 29.50 | 31.15 | 31.34 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.28 | 0.32 | 1.20 | -0.06 | -0.20 |
| Revenue Per Share | 27.07 | 28.86 | 26.08 | 33.23 | 28.02 |
| Net Income Per Share | -2.65 | -1.90 | 0.09 | 1.37 | 1.32 |
| Tax Burden | 0.72 | 0.69 | -0.19 | 1.05 | 1.17 |
| Interest Burden | 1.26 | 1.50 | -1.95 | 0.74 | 0.80 |
| Research & Development to Revenue | 0.19 | 0.17 | 0.14 | 0.09 | 0.10 |
| SG&A to Revenue | 0.22 | 0.30 | 0.30 | 0.29 | 0.29 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 |
| Income Quality | -1.98 | -0.11 | -6.38 | 1.65 | 3.62 |
Currency in TWD
